A Milestone Moment: FDA Approves Addyi® for Hypoactive Sexual Desire Disorder in Postmenopausal Women
December 17, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Baygam, GamaSTAN S/D, GamaSTAN, Biogam
Synonyms :
immune globulin IM (IGIM)
Class :
Immune globulins
Brand Name :
Baygam, GamaSTAN S/D, GamaSTAN, Biogam
Synonyms :
immune globulin IM (IGIM)
Class :
Immune globulins
Dosage Forms & Strengths
Injectable solution
16.5% protein/mL (2-mL, 5-mL single-dose vials)- GamaSTAN
15-18% [150-180 mg/mL] (2-mL, 5-mL, 10-mL single-dose vials)- GamaSTAN S/D
Indicates a susceptible person who has not had measles before and has not been vaccinated :
0.25
mL/kg
Intramuscular (IM)
Comments:
Avoid taking the measles vaccine at the same time.
0.1
mL/kg
Intramuscular (IM)
for the contacts of Household and institutional hepatitis A
Persons traveling to areas where hepatitis A is common:
Dosing is divided based on the duration of stay to areas where hepatitis A is common
For one month stay: 0.1 mL/kg intramuscularly IM
For two months stay: 0.2 mL/kg intramuscularly IM
More than two months stay: 0.2 mL/kg intramuscularly IM every two months
For Prophylaxis:
0.6 - 1.2
mL/kg
Intramuscular (IM)
within six days of exposure
Note: take only the varicella-zoster IG (Human) is unavailable
Dosage Forms & Strengths
Injectable solution
16.5% protein/mL (2-mL, 5-mL single-dose vials)- GamaSTAN
15-18% [150-180 mg/mL] (2-mL, 5-mL, 10-mL single-dose vials)- GamaSTAN S/D
Age: 12 months-40 years
0.1 mL/kg intramuscularly IM for the contacts of Household and institutional hepatitis A
Dosing is divided based on the duration of stay to areas where hepatitis A is common.
For one month stay: 0.1 mL/kg intramuscularly IM
For two months stay: 0.2 mL/kg intramuscularly IM
More than two months stay: 0.2 mL/kg intramuscularly IM every two months
Indicates a susceptible person who has not had measles before and has not been vaccinated :
0.25
mL/kg
Intravenous (IV)
Comments:
Avoid taking the measles vaccine at the same time.
For Prophylaxis: the dose of 0.6-1.2 mL/kg IM within six days of exposure
Note: take only the varicella-zoster IG (Human) is unavailable
may diminish the therapeutic effect of vaccines
vaccinia immune globulin intravenous (Rx)
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
may diminish the therapeutic effect of vaccines
measles mumps and rubella vaccine, live
may diminish the therapeutic effect of vaccines
measles, mumps, rubella and varicella vaccine, live
may decrease the therapeutic effects of vaccine
may enhance the thrombogenic effect of immune globulin
may enhance the thrombogenic effect of immune globulin
poliovirus vaccine, live, trivalent
may diminish the therapeutic effect of vaccines
poliovirus vaccine inactivated
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
smallpox (vaccinia) vaccine, live
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
immune globulins decrease the efficacy of live vaccines
measles mumps and rubella vaccine, live
immune globulins decrease the efficacy of live vaccines
immune globulins decrease the efficacy of live vaccines
smallpox (vaccinia) vaccine, live
immune globulins decrease the efficacy of live vaccines
immune globulins decrease the efficacy of live vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
they decrease the efficacy of live vaccines
measles mumps and rubella vaccine, live
they decrease the efficacy of live vaccines
Adverse drug reactions
Frequency Not Defined
Angioedema
Anaphylactic reaction
Urticaria
Local pain at the injection site
Post-marketing Reports
Injection site pain
Nausea
Fatigue
Headache
Pyrexia
Injection site inflammation
Pregnancy warnings:
AU TGA pregnancy category: Exempt
US FDA pregnancy category: Not assigned
Lactation:
Excreted into human milk is unknown
Pregnancy Categories:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were no enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: immune globulin IM (IGIM)
Why do we use immune globulin IM (IGIM)?
immune globulin IM (IGIM) is an Immune Globulin used to help prevent infection after exposure to Measles, Chickenpox (Varicella), Rubella, and Hepatitis A.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
